1 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
βGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
72PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITYβ Experimental GO Evidenceβ Swiss-Prot Reviewed
nucleoplasmenzyme bindingnucleusprotein bindingviral diseaseinfectious diseasedengue diseasehepatocellular carcinoma
Based on limited published evidence, H2AC11 is a histone H2A variant that functions as a structural component of chr6 and nucleosomes. Database annotations indicate roles in chr6 organization, heterochromatin formation, and protein binding within the nucleus and nucleoplasm. H2AC11 was identified as potentially relevant to COVID-19 disease severity in a large-scale bioinformatics study analyzing berberine's therapeutic mechanisms 1, though specific molecular mechanisms remain undefined. The gene's primary characterized function relates to nucleosome assembly and chr6 structural organization.
1
H2AC11 identified as closely related to COVID-19 disease severity in patients through large-scale dataset analysis of berberine therapeutic targets
PMID: 37033923β Limited data available β This gene has 1 indexed publication. Summary and analysis may be incomplete.
infectious diseaseOpen Targets
viral diseaseOpen Targets
dengue diseaseOpen Targets
hepatocellular carcinomaOpen Targets
metabolic syndromeOpen Targets
Nijmegen breakage syndromeOpen Targets
major depressive disorderOpen Targets
diffuse large B-cell lymphomaOpen Targets
Huntington diseaseOpen Targets
systemic lupus erythematosusOpen Targets
neuroblastomaOpen Targets
glioblastoma multiformeOpen Targets
mature T-cell and NK-cell non-Hodgkin lymphomaOpen Targets
lung adenocarcinomaOpen Targets
acute myeloid leukemiaOpen Targets
type 2 diabetes mellitusOpen Targets
No pathogenic variants reported on ClinVar for this gene.